LENSAR, Inc. (NASDAQ:LNSR – Get Free Report) saw a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 105,100 shares, a growth of 66.0% from the February 13th total of 63,300 shares. Currently, 1.2% of the shares of the company are sold short. Based on an average daily volume of 93,700 shares, the days-to-cover ratio is currently 1.1 days.
LENSAR Price Performance
Shares of LNSR stock traded up $0.53 on Friday, hitting $15.13. 130,806 shares of the stock traded hands, compared to its average volume of 112,453. The firm has a market cap of $178.37 million, a price-to-earnings ratio of -10.36 and a beta of 0.62. LENSAR has a 52 week low of $2.67 and a 52 week high of $16.40. The firm has a 50 day simple moving average of $10.72 and a two-hundred day simple moving average of $7.78.
LENSAR (NASDAQ:LNSR – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($1.40). LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%. The firm had revenue of $16.73 million for the quarter, compared to analysts’ expectations of $14.95 million.
Institutional Trading of LENSAR
Analysts Set New Price Targets
Separately, Lake Street Capital boosted their price target on shares of LENSAR from $12.00 to $16.00 and gave the stock a “buy” rating in a research note on Friday, February 28th.
Get Our Latest Stock Report on LENSAR
LENSAR Company Profile
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Featured Articles
- Five stocks we like better than LENSAR
- The How and Why of Investing in Gold Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Short Nasdaq: An Easy-to-Follow Guide
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Most Effectively Use the MarketBeat Earnings Screener
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.